[ 5/9 (Wed) ]
KPAC 2018 (Korea Pharma Associations Conference)



Representative Info. Hyun Hee Leem, +82-2-6263-2058, hyunhee.leem@mci-group.kr
* You could participate this session without additional registration.
Time Session Title
12 : 00 ~ 13 : 30 Policy luncheon RTM (Invitation Only)
13 : 30 ~ 14 : 10 Opening Remarks
14 : 10 ~ 14 : 25 Congratulatory Remarks
14 : 25 ~ 14 : 30 Photo Time
14 : 30 ~ 15 : 10 Keynote Speech (MNC : Cutting edge in new drug R&D with open innovation)
Philip Tagari, VP of Research, AMGEN
Panel Discussion
15 : 10 ~ 16 : 20 Session 1: Future of Oncology Biomarkers and How Open Innovation Works
Rosa Hee Jung Kim, Senior Manager, AstraZeneca
Hunwoo Shin, Director, BD&L, MSD
Byoung Chul Cho, Severance Hospital
16 : 40 ~ 17 : 50 Session 2: Implement 'Quick win fast fail strategy' for new drug R&D
Takao Honda , Sr. Manager, External Innovation, Eli Lilly Japan
Su Jin Ahn, Director, Yuhan
Hyun Ju Yang, Executive Director), Daiichi Sankyo Korea